PRAM1 anticorps (AA 551-650) (Biotin)
-
- Antigène Voir toutes PRAM1 Anticorps
- PRAM1 (PML-RARA Regulated Adaptor Molecule 1 (PRAM1))
-
Épitope
- AA 551-650
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PRAM1 est conjugé à/à la Biotin
-
Application
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Réactivité croisée
- Humain
- Homologie
- Mouse,Rat,Dog,Cow,Sheep,Pig,Horse
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human PRAM1
- Isotype
- IgG
- Top Product
- Discover our top product PRAM1 Anticorps primaire
-
-
- Indications d'application
-
IHC-P 1:200-400
IHC-F 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- PRAM1 (PML-RARA Regulated Adaptor Molecule 1 (PRAM1))
- Autre désignation
- PRAM1 (PRAM1 Produits)
- Synonymes
- anticorps PRAM1, anticorps AY665714, anticorps PML-RAR, anticorps PRAM-1, anticorps RGD1564330, anticorps PML-RARA regulated adaptor molecule 1, anticorps PML-RAR alpha-regulated adaptor molecule 1, anticorps PRAM1, anticorps Pram1
- Sujet
-
Synonyms: PML RAR, PML RARA regulated adaptor molecule 1, PML RARA target gene encoding an Adaptor Molecule 1, PML-RARA-regulated adapter molecule 1, PRAM 1, PRAM, PRAM-1, PRAM_HUMAN, PRAM1.
Background: Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia cells. The retinoic acid-induced gene, PRAM-1 (PML-RAR-a target gene encoding an adaptor molecule 1) encodes an adaptor protein which is expressed and modulated during normal human myelopoiesis. PRAM-1 expression is hindered by expression of PML-RAR-a. The 718 amino acid PRAM-1 protein contains eight N-terminal proline-rich repeats and several proline residues that are clustered as type I or type II SH3 recognition motifs. PRAM-1 demonstrates expression in hematopoietic tissues and lung.
- Pathways
- Regulation of Leukocyte Mediated Immunity
-